Boehringer Ingelheim has breathed life into an American Lung Association campaign, providing support for a new push to educate people with bronchiectasis about how to better manage the disease.

Boehringer Ingelheim has launched Vetmedin (pimobendan) 1.5 mg/ml oral solution for dogs in the UK, offering a new treatment ...

Physicians treating patients with Crohn's disease face a plethora of drug choices. Yet, overall rates of clinical response seem stable over time,1 suggesting the existence of a therapeutic ceiling ...

Weber Shandwick MENAT has launched the second edition of InfluAnswer Arabia, a report informed by the perspectives of cont ...

The clinical trial support services market is experiencing significant growth, driven by the increasing incidence of chronic illnesses such as cancer ...

Today, on World Bronchiectasis Day, the American Lung Association is launching a new campaign to support people living with ...

Rinri Therapeutics, a world leading spinout company from the University of Sheffield dedicated to transforming sensorineural ...

Rinri Therapeutics, a leading University of Sheffield spin-out company dedicated to transforming the treatment of sensorineural hearing loss with a ...

Galapagos announces leadership transition. European biotechnology company Galapagos completed a significant leadership ...

UK MHRA Approval Received for First-In-Human Trial of Rincell-1, a First-In-Class Regenerative Cell Therapy for Sensorineural ...

Gen Z billionaires are here! With some leading their companies while others pursue college degrees or quiet lives, these are ...

A new study led by Johns Hopkins researchers has identified a significant gap between the number of U.S. patients for whom cholesterol-lowering drugs ...